USD 1.74 billion
Report ID:
SQMIG35A2818 |
Region:
Global |
Published Date: April, 2025
Pages:
219
|Tables:
91
|Figures:
74
Safety Lancet Market size was valued at USD 1.74 billion in 2023 and is poised to grow from USD 1.91 billion in 2024 to USD 3.94 billion by 2032, growing at a CAGR of 9.5% during the forecast period (2025-2032).
The safety lancet market is witnessing substantial growth, driven primarily by the increasing prevalence of diabetes and infectious diseases. Lancets have gained prominence in the healthcare industry, serving crucial roles in blood glucose monitoring and various diagnostic tests. The market's momentum is propelled by the surging demand for user-friendly, single-use lancets that provide enhanced safety and convenience.
Emerging markets such as India and China present growth opportunities for companies in the lancet market, supported by the rising number of healthcare facilities and growing healthcare awareness among the population. Despite these positive trends, certain factors impede market growth. Concerns about needlestick injuries, which pose the risk of infectious disease transmission, especially among healthcare workers using lancets, remain significant. Additionally, the potential for infection due to the reuse of lancets highlights the increasing adoption of single-use lancets as a safer and more prevalent practice in healthcare settings.
Market snapshot - 2025-2032
Global Market Size
USD 1.74 billion
Largest Segment
Hospital
Fastest Growth
Growth Rate
9.5% CAGR
To get more reports on the above market click here to Buy The Report
Global Safety Lancet Market is segmented by Product Type, Application, End User and region. Based on Product Type, the market is segmented into Push Button Safety Lancet, Pressure Activated Safety Lancet and Side Button Safety Lancet. Based on Application, the market is segmented into Blood Glucose Testing, Haemoglobin Testing, Cholesterol Testing and Coagulation Testing. Based on End User, the market is segmented into Hospitals and Clinics, Diagnostic Centers and Pathology Laboratories, Home Diagnostics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
The push button safety lancet market is experiencing rapid growth due to increased demand for safe, user-friendly, and reliable blood sampling devices. These lancets, designed to reduce the risk of needlestick injuries and improve patient comfort, are particularly popular in diabetic care and home testing. Enhanced safety features and ease of use make them a preferred choice, driving their adoption across various healthcare settings and boosting market expansion.
The Side Button Safety Lancet segment is dominating the market due to its user-friendly design, ensuring minimal pain and easy handling, making it highly preferred in medical and home care settings. Its safety features, such as automatic needle retraction, reduce the risk of needlestick injuries, enhancing patient and healthcare worker safety. This market leadership is further driven by growing awareness and demand for safe and efficient blood sampling devices.
In 2023, the hospital segment led the market and is expected to maintain this position through the forecast period. This dominance is due to the rising incidence of infectious diseases and a large diabetic patient population, both requiring extensive blood testing. The high demand for diagnostic testing within hospital settings significantly contributes to the segment's prominence.
The home care segment is projected to grow the fastest during the forecast period due to increasing preference for self-monitoring of blood glucose. This surge is driven by rising awareness about the importance of self-monitoring and the availability of various lancet devices. The convenience and cost-effectiveness of home blood glucose measurement significantly contribute to this segment's rapid expansion.
To get detailed analysis on other segments, Request For Free Sample Report
In 2023, North America asserted its dominance in the market, driven by various factors, including a substantial patient pool and favorable reimbursement policies. The region's leading position is further reinforced by the increasing frequency of new product launches and a consistent rise in healthcare expenditure, contributing significantly to market growth. Notably, The International Diabetes Federation reports that a substantial 43% of the total diabetes-related health expenditure occurs in North America, underscoring the region's pivotal role in the market.
The Asia Pacific is poised for the fastest growth during the forecast period, propelled by improving healthcare infrastructure and a sizable patient pool necessitating diagnostic tests for effective treatment. The region's accelerated growth is further fueled by the rising incidence of infectious diseases, including arboviral diseases such as dengue, Zika, West Nile, malaria, and chikungunya. The escalating demand for lancing devices in response to the increased need for diagnostic testing aligns with the broader healthcare trends in the Asia Pacific, highlighting the region's significance in the market's evolving landscape.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Rising Prevalence of Diabetes
Low Awareness among Individuals
Request Free Customization of this report to help us to meet your business objectives.
The competitive environment of the Safety Lancet market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. Leading brands invest in research and development to introduce new flavors, packaging formats, and health-focused variations to cater to changing consumer preferences. They often set the trends in the industry.
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research. Several significant drivers are anticipated to fuel the growth of the safety lancet market, including the increasing prevalence of diabetes, the substantial growth in the number of insulin users, and a rising incidence rate of both contagious and non-contagious diseases. Safety lancets play a crucial role in various medical applications, being utilized for heel-stick screening tests, diabetes and glucose testing, as well as tests in infants. Furthermore, their use extends to scenarios involving scarred emergency patients or severely burned patients, contributing to their versatility and expanding their market applications.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 1.74 billion |
Market size value in 2032 | USD 3.94 billion |
Growth Rate | 9.5% |
Base year | 2024 |
Forecast period | 2025-2032 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Safety Lancet Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Safety Lancet Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Safety Lancet Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Safety Lancet Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Safety Lancet Market size was valued at USD 1.74 Billion in 2023 and is poised to grow from USD 1.91 Billion in 2024 to USD 3.94 Billion by 2032, growing at a CAGR of 9.5% during the forecast period (2025-2032).
The competitive environment of the Safety Lancet market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. Leading brands invest in research and development to introduce new flavors, packaging formats, and health-focused variations to cater to changing consumer preferences. They often set the trends in the industry. 'Roche Diagnostics (Basel, Switzerland)', 'Abbott Laboratories (Illinois, United States)', 'Becton, Dickinson and Company (New Jersey, United States)', 'Terumo Medical Corporation (Tokyo, Japan)', 'Cardinal Health, Inc. (Ohio, United States)', 'Greiner Bio-One International GmbH (Frickenhausen, Germany)', 'HTL-STREFA S.A. (Ozorków, Poland)', 'Sarstedt AG & Co. KG (Nümbrecht, Germany)', 'Nipro Corporation (Osaka, Japan)', 'Improve Medical Technology Co. Ltd. (Guangzhou, China)', 'Simple Diagnostics (Florida, United States)', 'Ypsomed AG (Burgdorf, Switzerland)', 'Owen Mumford Ltd. (Oxfordshire, United Kingdom)', 'Arkray Inc. (Kyoto, Japan)', 'Perrigo Company plc (Dublin, Ireland)', 'Smiths Medical (Minnesota, United States)', 'Medline Industries, Inc. (Illinois, United States)', 'Omron Healthcare, Inc. (Kyoto, Japan)'
The safety lancet market is undergoing substantial growth, propelled by the escalating burden of diabetes, a health crisis expected to double within the next 25 years. This surge is attributed to the rising incidence of both type 1 and type 2 diabetes, posing a significant financial burden on healthcare systems worldwide. Contributing factors to the surge in diabetes cases encompass lifestyle elements such as obesity, smoking, sedentary behaviors, and increasing urbanization. With a higher prevalence in older populations, the aging demographic is anticipated to further amplify the diabetic population. In response to this growing health challenge, the adoption of safety lancets is poised to increase during the forecast period.
The safety lancet market has experienced substantial growth, largely attributed to significant technological advancements in the design and manufacturing of lancets. Traditional lancets were simplistic, single-use devices featuring a sharp blade for puncturing the skin to collect blood samples. However, technological progress has led to the evolution of safety lancets, making them more sophisticated and safer in application. One notable advancement driving market growth is the development of retractable lancets. Retractable lancets are equipped with a mechanism that retracts the needle back into the lancet body after use, effectively eliminating the risk of accidental needlestick injuries.
In 2023, North America asserted its dominance in the market, driven by various factors, including a substantial patient pool and favorable reimbursement policies. The region's leading position is further reinforced by the increasing frequency of new product launches and a consistent rise in healthcare expenditure, contributing significantly to market growth. Notably, The International Diabetes Federation reports that a substantial 43% of the total diabetes-related health expenditure occurs in North America, underscoring the region's pivotal role in the market.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35A2818
[email protected]
USA +1 351-333-4748